TauGen Files Patent Application for Novel TBI Drug Candidates

TauGen, LLC, in collaboration with CereMark Pharma, has filed a US patent application for a new class of drug candidates targeting traumatic brain inj...
Home/KnloSights/Clinical Trial Updates/TauGen Files Patent Application for Novel TBI Drug Candidates